AIIMS Director Proposes Integration of Ayurveda and Modern Allopathy

Dr. Puranik was addressing the second Foundation Day celebration of the Indian Ayurvedic Medical College (IAMC) at the University of Science and Technology Meghalaya (USTM)...

Dr Reddy's Secures CDSCO Nod, Becomes First to Launch Elobixibat in India

Dr Reddy's is the first leading pharmaceutical company to obtain approval from the Central Drugs Standard Control Organisation (CDSCO) to introduce Elobixibat in India. Elobixibat works by preventing bile acids from being reabsorbed in the ileum...

Medtronic Gains US FDA Nod for AFib Mapping and Ablation System

Medtronic plc, a prominent player in healthcare technology worldwide, revealed that the FDA has given the green light for the Affera Mapping and Ablation System with Sphere-9 catheter, a comprehensive HD mapping and PF/RF ablation catheter for...

Merck's Keytruda Bags European Nod for indications in Gynaecologic Cancers

Merck, a leading pharmaceutical firm, stated that Keytruda (pembrolizumab), their anti-PD-1 therapy, has received approval from the European Commission (EC) for two additional uses in gynaecologic cancers. Keytruda has received initial approval...

Eli Lilly's Donanemab Secures MHRA Approval for Alzheimer's Treatment

Eli Lilly and Company, a pharmaceutical company that uses science to improve lives globally, has revealed that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the marketing of donanemab, an injection for intravenous...

Zydus Receives WHO Approval for its Typhoid Vaccine

Zydus Lifesciences announced that their typhoid vaccine ZyVac TCV has been granted preliminary acceptance by the World Health Organisation (WHO). The WHO's pre-qualification will allow United Nations (UN) agencies to buy ZyVac TCV. ZyVac TCV is...

Thermo Fisher's Oncomine Test Wins FDA Approval for VORANIGO Treatment

Thermo Fisher Scientific, the global leader in scientific services, has been granted FDA approval for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic to select patients suitable for treatment with Servier Pharmaceuticals, LLC’s...

Alembic Pharma Receives USFDA Nod for generic hypertension treatment Capsules

Alembic Pharmaceuticals Ltd announced that it has obtained approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules, which are used for treating hypertension. The company stated that the USFDA has...

US FDA Nod GSK's Gepotidacin NDA for Treating Urinary Tract Infections

GSK plc reported that the NDA for gepotidacin, a new oral antibiotic for treating female adults and adolescents with uUTIs, has been accepted by the US FDA. The FDA has decided to give Priority Review to this application and has set a PDUFA action...

Bayer Seeks EMA Approval for Elinzanetant to treat vasomotor symptoms

The biotechnology firm Bayer has requested approval from the European Medicines Agency (EMA) for elinzanetant to treat moderate to severe vasomotor symptoms (VMS, commonly known as hot flashes) linked to menopause or triggered by adjuvant...